THE ROLE OF THE PHARMACIST IN THE TREATMENT OF PATIENTS WITH TYPE II DIABETES MELLITUS: A LITERATURE REVIEW
DOI:
https://doi.org/10.47820/recima21.v4i10.4229Keywords:
Diabetes Mellitus, drug treatment, Role of the pharmacistAbstract
Type 2 Diabetes Mellitus is considered a multifactorial health problem, very common in Brazil and worldwide. Thus, research is done on the role of the Pharmacist in the treatment of patients with type 2 Diabetes Mellitus with the result of providing knowledge about the importance of this professional in the treatment of type 2 Diabetes Mellitus. Therefore, it is necessary to conceptualize type 2 Diabetes Mellitus and relate the treatment of Diabetes with the patient's lifestyle and highlight the importance of the Pharmacist in supporting the diabetic patient. A literature review is then carried out. From this, it is possible to verify that the Pharmaceutical professional is a fundamental part in the treatment that contributes to a higher quality of life of the patient. It is the Pharmacist who participates in the medication orientation and the changes to be made in the patient's daily life for a better control of DM2. In this context, the quality of life factor becomes more evident among patients and health professionals. Thus, the role of the Pharmacist is reinforced, indispensable, in the multidisciplinary team responsible for the treatment of patients, by the various capacities of this professional regarding the orientation of the treatment, a crucial factor for survival and better quality of life of patients with type 2 Diabetes Mellitus.
Downloads
References
International Diabetes Federation (IDF). (2019). IDF Diabetes Atlas, 9th edn. Brussels, Belgium: IDF.
International Diabetes Federation (IDF). (2021). IDF Diabetes Atlas, 11th edn. Brussels, Belgium: IDF.
American Diabetes Association. (2019). Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 42(Supplement 1), S13-S28. doi:10.2337/dc19-S002
International Diabetes Federation (IDF). (2020). IDF Diabetes Atlas, 10th edn. Brussels, Belgium: IDF.
American Diabetes Association. (2020). 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020. Diabetes Care, 43(Supplement 1), S14-S31. doi:10.2337/dc20-S002
Kahn, S. E., Cooper, M. E., & Del Prato, S. (2014). Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. The Lancet, 383(9922), 1068-1083. doi:10.1016/S0140-6736(13)62154-6
American Diabetes Association. (2018). Economic Costs of Diabetes in the U.S. in 2017. Diabetes Care, 41(5), 917-928. doi:10.2337/dci18-0007
Lee, Y. K., Chin, T. Y., & Liong, M. L. (2018). Impact of Pharmacist-Managed Diabetes Mellitus Clinic in Hypertensive Patients with Type 2 Diabetes Mellitus. Journal of Managed Care & Specialty Pharmacy, 24(11), 1151-1159. doi:10.18553/jmcp.2018.24.11.1151
Zillich, A. J., Sutherland, J. M., Kumbera, P. A., Carter, B. L., & Doucette, W. R. (2005). Hypertension Outcomes Through Blood Pressure Monitoring and Evaluation by Pharmacists (HOME Study). Journal of General Internal Medicine, 20(12), 1091-1096. doi:10.1111/j.1525-1497.2005.0244
Sokol, M. C., McGuigan, K. A., Verbrugge, R. R., & Epstein, R. S. (2005). Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost. Medical Care, 43(6), 521-530. doi:10.1097/01.mlr.0000163641. 86870.a0
McAdam-Marx, C., Bellows, B. K., Unni, S., Wygant, G., Mukherjee, J., Ye, X., ... & Brixner, D. I. (2013). Impact of adherence and weight loss on glycemic control in patients with type 2 diabetes: cohort analyses of integrated pharmacy claims data. BMJ Open Diabetes Research & Care, 1(2), e000058. doi:10.1136/bmjdrc-2013-000058
Chisholm-Burns, M. A., Kim Lee, J., Spivey, C. A., Slack, M., & Herrier, R. N. (2010). US pharmacists' effect as team members on patient care: systematic review and meta-analyses. Medical Care, 48(10), 923-933. doi:10.1097/MLR.0b013e3181e57962
DeCastro, L., Acker, C. G., Corrigan, K. A., Corrigan, K. A., Santos, C. A., & Glass, M. (2018). Pharmacist-Provided Education for Hospitalized Patients with Uncontrolled Diabetes Mellitus. American Journal of Health-System Pharmacy, 75(22), 1786-1793. doi:10.2146/ajhp170892
El-Kebbi, I. M., Ziemer, D. C., Cook, C. B., Gallina, D. L., Barnes, C. S., Dunbar, V. G., ... & Phillips, L. S. (2005). Utility of HbA1c levels for diabetes case finding in hospitalized patients with hyperglycemia. Diabetes Care, 28(7), 1821-1822. doi:10.2337/diacare.28.7.1821
Downloads
Published
License
Copyright (c) 2023 RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218
This work is licensed under a Creative Commons Attribution 4.0 International License.
Os direitos autorais dos artigos/resenhas/TCCs publicados pertecem à revista RECIMA21, e seguem o padrão Creative Commons (CC BY 4.0), permitindo a cópia ou reprodução, desde que cite a fonte e respeite os direitos dos autores e contenham menção aos mesmos nos créditos. Toda e qualquer obra publicada na revista, seu conteúdo é de responsabilidade dos autores, cabendo a RECIMA21 apenas ser o veículo de divulgação, seguindo os padrões nacionais e internacionais de publicação.
